ReviewCureus2025
Electroconvulsive Therapy for Obsessive-Compulsive Symptoms in Schizophrenia Spectrum Disorders: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterizing executive dysfunctions in patients with schizo-obsessive comorbidity: comparing schizophrenia with obsessive-compulsive disorder.Psychological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obsessive-compulsive symptoms (OCS) and obsessive-compulsive disorder (OCD) can co-occur with schizophrenia spectrum disorders. There is limited research on electroconvulsive therapy (ECT) for this particular comorbidity. This systematic review assessed the efficacy of ECT for OCS/OCD in patients with schizophrenia spectrum disorders. A systematic literature search was conducted using multiple databases. Inclusion criteria for articles included those involving patients with both OCS/OCD and schizophrenia spectrum disorders treated with ECT. Out of 10 studies, 11 patients met the inclusion criteria. Nine were case reports and one was a retrospective study. Seven out of 11 patients experienced improvement in OCS after ECT, including four with complete remission. Additionally, two acutely suicidal patients due to OCS/OCD had remission of suicidality. The mean reduction in Yale-Brown Obsessive Compulsive Scale scores across four patients was 29.5±7.7. Maintenance ECT was effective in preventing relapse in three patients. No worsening of symptoms or major adverse effects were reported. ECT may offer a potentially beneficial treatment option for OCS/OCD in patients with schizophrenia spectrum disorders, particularly those with treatment-resistant or severe symptoms. The small number of patients, predominance of case studies, and heterogeneous evidence limit conclusions and treatment guidance. Further studies are necessary to determine efficacy, adverse effects, and optimal use of ECT in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.